Clinical Genomics


HiSeqX facility

Photo credit: P. Morris/Garvan

Overview

The Kinghorn Centre for Clinical Genomics (KCCG) was established by the Garvan Institute in 2012 to advance the use of genomic information in patient care. KCCG employs world-leading DNA sequencing technology and expertise in genetics, pathology and bioinformatics to deliver and interpret genome sequences for research and clinical use. Find out more about our mission and vision in About KCCG.

Clinical Application

KCCG acts as a mechanism to translate genomic research into the clinic, and has recently obtained accreditation to enable it to provide state-of-the-art interpretation of genomic data directly to clinicians. From the 1st of August 2016, clinical whole genome sequencing services for diagnosis of rare and genetic disease is available through Garvan's wholly owned subsidiary company, Genome.One.

Public and professional engagement will be vital to realising the potential of clinical genomics in Australia, and the Centre is developing programs, resources and opportunities for health practitioners and communities to learn about genomics.

Technology and Partnerships

In 2014, Garvan acquired a HiSeq X Ten sequencing platform, which provides KCCG with powerful genome sequencing potential and the capability to sequence up to 18,000 whole human genomes per year. Researchers with ethically-approved projects can order genomes from our facility. In 2014, the Centre became a genomics node of BioPlatforms Australia.

Research Scope

Research at the KCCG is focused on improving the value and interpretation of genomes for patient care.  The Centre will continue to facilitate genome-based research, initially in cancer and monogenic diseases, but also in complex disease such as diabetes, osteoporosis and immunological disease.

In the News

Loading jobs...